|
Originally published In Press as doi:10.1074/jbc.M403581200 on April 19, 2004
J. Biol. Chem., Vol. 279, Issue 25, 26331-26338, June 18, 2004
Formation of Biologically Active Oxysterols during Ozonolysis of Cholesterol Present in Lung Surfactant*
Melissa K. Pulfer and
Robert C. Murphy
From the
Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80206
Exposure of the lung to concentrations of ozone found in ambient air is known to cause toxicity to the epithelial cells of the lung. Because of the chemical reactivity of ozone, it likely reacts with target molecules in pulmonary surfactant, a lipid-rich material that lines the epithelial cells in the airways. Phospholipids containing unsaturated fatty acyl groups and cholesterol would be susceptible to attack by ozone, which may lead to the formation of cytotoxic products. Whereas free radicalderived oxidized cholesterol products have been frequently studied for their cytotoxic effects, ozonized cholesterol products have not been studied, although they could reasonably play a role in the toxicity of ozone. The reaction of ozone with cholesterol yielded a complex series of products including 3 -hydroxy-5-oxo-5,6-secocholestan-6-al, 5-hydroperoxy-B-homo-6-oxa-cholestan-3 ,7a-diol, and 5 ,6 -epoxycholesterol. Mass spectrometry and radioactive monitoring were used to identify the major cholesterol-derived product during the reaction of 2 ppm ozone in surfactant as 5 ,6 -epoxycholesterol, which is only a minor product during ozonolysis of cholesterol in solution. A dose-dependent formation of 5 ,6 -epoxycholesterol was also seen during direct exposure of intact cultured human bronchial epithelial cells (16-HBE) to ozone. Studies of the metabolism of this epoxide in lung epithelial cells yielded small amounts of the expected metabolite, cholestan-3 ,5 ,6 -triol, and more abundant levels of an unexpected metabolite, cholestan-6-oxo-3 ,5 -diol. Both 5 ,6 -epoxycholesterol and cholestan-6-oxo-3 ,5 -diol were shown to be cytotoxic to cultured 16-HBE cells. A possible mechanism for cytotoxicity is the ability of these oxysterols to inhibit isoprenoid-based cholesterol biosynthesis in these cells.
Received for publication, March 31, 2004
, and in revised form, April 14, 2004.
* This work was supported in part by NIEHS Grant ES012347 and National Institutes of Health Grant HL34303. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206. Tel.: 303-398-1849; Fax: 303-398-1694; E-mail: murphyr{at}njc.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. C. Murphy and K. M. Johnson
Cholesterol, Reactive Oxygen Species, and the Formation of Biologically Active Mediators
J. Biol. Chem.,
June 6, 2008;
283(23):
15521 - 15525.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Manzer, J. Wang, K. Nishina, G. McConville, and R. J. Mason
Alveolar Epithelial Cells Secrete Chemokines in Response to IL-1beta and Lipopolysaccharide but Not to Ozone
Am. J. Respir. Cell Mol. Biol.,
February 1, 2006;
34(2):
158 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Agassandian, J. Zhou, L. A. Tephly, A. J. Ryan, A. B. Carter, and R. K. Mallampalli
Oxysterols Inhibit Phosphatidylcholine Synthesis via ERK Docking and Phosphorylation of CTP:Phosphocholine Cytidylyltransferase
J. Biol. Chem.,
June 3, 2005;
280(22):
21577 - 21587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Pulfer, C. Taube, E. Gelfand, and R. C. Murphy
Ozone Exposure in Vivo and Formation of Biologically Active Oxysterols in the Lung
J. Pharmacol. Exp. Ther.,
January 1, 2005;
312(1):
256 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Meaney, T. L. Bonfield, M. Hansson, A. Babiker, M. S. Kavuru, and M. J. Thomassen
Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis
J. Lipid Res.,
December 1, 2004;
45(12):
2354 - 2360.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|